Evidence map›Paper›PMID 33549473›Full record

ReviewTrends in molecular medicine2021

Delaying Reproductive Aging by Ovarian Tissue Cryopreservation and Transplantation: Is it Prime Time?

Kutluk H Oktay, Loris Marin, Boris Petrikovsky, Michael Terrani, Samir N Babayev

Open access · greenAbstract readReview
In one paragraph

Review in Trends in molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Significance and Influence of Suturing for Ovarian Tissue Transplantation.Reproductive sciences (Thousand Oaks, Calif.) · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. The Aging Ovary and the Tales Learned Since Fetal Development.Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Kutluk H OktayDepartment of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA; Innovation Institute for Fertility Preservation, New York, NY, USA. Electronic address: correspondence@fertilitypreservation.org.
Loris MarinDepartment of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA; Department of Women's and Children's Health, University of Padua, Padua, Italy.
Boris PetrikovskyNew York Institute for Technology, New York, NY, USA.
Michael TerraniGarden OB/GYN, Garden City, NY, USA.
Samir N BabayevDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Foundation for Child Development · USGarden City Community College · USMayo Clinic in Arizona · USNew York Institute of Technology · USYale University · US

Funding

Characterization & Prevention of Chemotherapy-Induced Damage to Ovarian ReserveR01HD053112 · NICHD · YALE UNIVERSITY · PI KUTLUK H OKTAY · 2007 to 2026
$7.6M
Improving Primordial Follicle Survival After Transplantation of Cryopreserved HumR21HD061259 · NICHD · NEW YORK MEDICAL COLLEGE · PI OKTAY, KUTLUK H · 2011 to 2012
$443k
NICHD NIH HHS R01 HD053112NICHD NIH HHS R21 HD061259
6 · The paper itself

Abstract

Ovarian tissue cryopreservation and autotransplantation can restore ovarian endocrine function and fertility and recently were changed from experimental to fertility preservation procedures for medical indications by the American Society of Reproductive Medicine. Such advances have resulted in discussions around the utility of ovarian cryopreservation in healthy women to preserve fertility and delay menopause or as a hormone replacement approach. Such 'elective' use of ovarian tissue cryopreservation requires a risk-benefit assessment. Here, we review evidence for and against the utility of ovarian tissue harvesting in healthy women, scrutinize recent and needed advances to enhance the feasibility of such an approach, and provide practice and future research guidelines.

Indexed as

Cell TransplantationCryopreservationReproductionReproductive Physiological PhenomenaAge FactorsAgingFemaleFertility PreservationHealth Impact AssessmentHumansMenopauseOvaryelective fertility preservationfertility preservation in healthy womenovarian tissue cryopreservation and transplantationreproductive agingtranslational research

Identifiers

PMID33549473
PMCPMC8427891
OpenAlexW3126440191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.